VERAXA Achieves Key Regulatory Milestone for BiTAC-TCE
ZURICH, Switzerland, July 20, 2026 VERAXA Biotech AG (NASDAQ: VRXA) announced that it has received Scientific Advice from Germany’s...
Preclinical Data
Advertisement
BioLineRx to Present GLIX1 Ovarian Cancer Data at ESMO 2026
TEL AVIV, Israel & OSLO, Norway, July 20, 2026 BioLineRx Ltd. and Hemispherian AS have announced that new preclinical...
Evaxion to Present EVX-V1 CMV Vaccine Preclinical Data
COPENHAGEN, Denmark, July 1, 2026 Evaxion A/S announced that it will present new preclinical data for its investigational cytomegalovirus...
Century Therapeutics Highlights CNTY-813 Data at ADA
PHILADELPHIA, Pennsylvania, April 2026 Century Therapeutics announced that its investigational program CNTY-813 has been selected for oral presentation at...
Telomir-1 Shows Strong Leukemia Cell-Killing Activity
WILMINGTON, DE — November 21, 2025 — Telomir Pharmaceuticals announced new preclinical findings showing that its investigational compound Telomir-1...
Advertisements
Verismo Therapeutics Unveils Promising CAR T Advances for Solid Tumors at SITC 2025
Philadelphia, November 10, 2025 — Verismo Therapeutics, a clinical-stage biotechnology company pioneering KIR-CAR T cell therapies, presented compelling preclinical...
Abalos Therapeutics’ ABX-001 Validated in Cell Reports Medicine
October 14, 2025 | Düsseldorf, Germany — Abalos Therapeutics announced the publication of preclinical proof-of-concept data in Cell Reports...
Silexion’s SIL204 Shows Preclinical Promise in Pancreatic Cancer
GRAND CAYMAN, Cayman Islands, Sept. 11, 2025 – Silexion Therapeutics Corp. (NASDAQ: SLXN), a clinical-stage biotechnology company developing RNA...
Advertisement
